Everybody can cheer and rah-rah and hope the FDA approves these substances, Brunner says
There was no plateau, and in fact it appears longer term trials will probably easily clear 20% weight loss, especially if metformin and/or SGLT2i medications are added on as these can both add another 2-3% extra weight loss when combined with a GLP-1 medication
GLP-1 agonists, on the other hand, are medications originally developed for managing type 2 diabetes and obesity
Others maintain benefits with less frequent treatments
For Convenience-First Users: Capsules Capsule-based BPC157 may appeal to: Supplement users who prefer no needles Individuals experimenting with daily low-dose use Those who understand the trade-off in efficacy However, the majority of capsule products lack the dosing consistency and purity required for therapeutic benefit
doi: 10.1016/j.jos.2020.03.010 88 YamanakaYGingeryAOkiGYangTHZhaoCAmadioPC